Carlsmed closed at $15.96 on Nov 4, up 10.83%, 6.1% below its 52-week closing high. Volume of 59.1K shares was 0.79× its 20-day average (below normal).
Split-adjusted performance: +9.0% over one month, +62.2% over six months, +30.6% over one year.
In the quarter ended Jun 30, 2026, revenue was $18.94M, with a net margin of -55.5%.
Short interest was 1.1M shares at the Oct 15 settlement, up 3.9% from the prior report (11.3% of float, 13.6 days to cover).